Objectives: The purpose of this study was to clarify the cause of decreased metabolic clearance of losartan in patients with end-stage renal failure. The influence of serum from haemodialysis patients (uraemic serum) and uraemic toxins on the metabolism of losartan to EXP-3174 was investigated in vitro. Methods: The formation of EXP-3174 was estimated using pooled human liver microsomes. 3-Carboxy-4-methyl-5-propyl-2-furanpropanoic acid, hippuric acid, indole-3-acetic acid, 3-indoxyl sulfate and p-cresol were used as uraemic toxins. Key findings: Uraemic serum potently decreased the formation of EXP-3174 in pooled human liver microsomes. In addition, 3-indoxyl sulfate and p-cresol significantly decreased the formation of EXP-3174 in a concentration-dependent manner. Furthermore, normal serum (10% v/v) with both 3-indoxyl sulfate and p-cresol (both 20 μmol/l) significantly decreased the formation of EXP-3174 by 46%, which was similar to the level of inhibition with uraemic serum (10% v/v). Conclusions: These results suggest that decreased the metabolic clearance o f losartan in patients with end-stage renal failure is partly due to high concentrations of 3-indoxyl sulfate and p-cresol. © 2010 The Authors.
CITATION STYLE
Tsujimoto, M., Higuchi, K., Shima, D., Yokota, H., Furukubo, T., Izumi, S., … Nishiguchi, K. (2010). Inhibitory effects of uraemic toxins 3-indoxyl sulfate and p -cresol on losartan metabolism in vitro. Journal of Pharmacy and Pharmacology, 62(1), 133–138. https://doi.org/10.1211/jpp.62.01.0015
Mendeley helps you to discover research relevant for your work.